Drug Delivery Systems: Entering the Mainstream
Why is this work in the frame?
A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.
Abstract
Drug delivery systems (DDS) such as lipid- or polymer-based nanoparticles can be designed to improve the pharmacological and therapeutic properties of drugs administered parenterally. Many of the early problems that hindered the clinical applications of particulate DDS have been overcome, with several DDS formulations of anticancer and antifungal drugs now approved for clinical use. Furthermore, there is considerable interest in exploiting the advantages of DDS for in vivo delivery of new drugs derived from proteomics or genomics research and for their use in ligand-targeted therapeutics.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
The record
- Venue
- Science
- Topic
- Nanoparticle-Based Drug Delivery
- Field
- Materials Science
- Canadian institutions
- Inimex Pharmaceuticals (Canada)University of AlbertaUniversity of British Columbia
- Funders
- —
- Keywords
- Drug deliveryDrugTargeted drug deliveryPharmacologyAntifungalMedicineComputational biologyNanotechnologyBiologyMaterials science
- Has abstract in OpenAlex
- yes